The School of Medicine Kl2 Mentored Career Development Program is a two-year research program funded by the National Institutes of Health (NIH) and the Stanford Clinical Translational Science Award (CTSA) Program.
c-ShARP welcomes collaborative proposals for instrument acquisitions, programs, or other enhancements to Shared Research Platforms and Shared Facilities. Faculty & staff are welcome to apply for FY25 funding.
The sustainability accelerator aims to co-create and scale solutions for climate and sustainability challenges globally. This request for proposals is for solutions for greenhouse gas removal from the atmosphere.
Stanford University’s Innovative Medicines Accelerator (IMA) is accepting proposals that address two major challenges in drug development: identifying drug candidates and optimization towards clinical leads.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
Stanford University’s Innovative Medicines Accelerator (IMA) is accepting proposals for projects that use a recent advance in human organ modeling to address the IMA’s goals of accelerating the prototyping of innovative medicines and vaccines.
DUE: October 2nd The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies & therapies are intended to lead to licensing exits to eventually reach the patient.
To support biomedical research in diabetes, the Stanford Diabetes Research Center (SDRC) invites applications for the 2023-24 Pilot and Feasibility (P&F) Program led by Drs. Anna Gloyn and Sun H Kim.
The goal of the Institute for Human-Centered Artificial Intelligence research program is to foster interdisciplinary AI research that aims to improve the human condition. We seek proposals for up to $75,000 that support new ambitious ideas.
